CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 87.41% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

Scan to Download iOS&Android APP

Trade Jupiter Wellness, Inc. - JUPW CFD

-
0%
  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread -
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.0308 %
Charges from borrowed part ($-1.23)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Go to platform
-0.0308%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.0308 %
Charges from borrowed part ($-1.23)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Go to platform
-0.0137%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency USD
Margin 20%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Key Stats
Prev. Close* N/A
Open* N/A
1-Year Change* N/A
Day's Range* N/A
52 wk Range 0.59-1.64
Average Volume (10 days) 0.72999
Average Volume (3 months) 7.70092
Market Cap 26.0478
P/E Ratio N/A
Shares Outstanding 21888900
Revenue 6.83655
EPS -1.00737
Dividend (Yield %) N/A
Beta N/A
Next Earnings Date N/A

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low

Jupiter Wellness, Inc. Events

Time (UTC) Country Event
No events scheduled
View all events
  • Annual
  • Quarterly
2018 2019 2020 2021
Total revenue 0 0.00646 1.06567 2.87627
Revenue 0 0.00646 1.06567 2.87627
Cost of Revenue, Total 0 0.01802 0.62457 2.34079
Gross Profit 0 -0.01156 0.4411 0.53548
Total Operating Expense 0.05973 0.92674 7.24111 29.2782
Selling/General/Admin. Expenses, Total 0.04323 0.79976 5.16446 16.0394
Research & Development 0.0165 0.10896 0.30837 1.07936
Operating Income -0.05973 -0.92028 -6.17544 -26.402
Interest Income (Expense), Net Non-Operating 0 -0.00518 -0.11376 -1.72879
Net Income Before Taxes -0.05973 -0.92546 -6.28921 -28.1003
Net Income After Taxes -0.05973 -0.92546 -6.28921 -28.1003
Net Income Before Extra. Items -0.05973 -0.92546 -6.28921 -28.1003
Net Income -0.05973 -0.92546 -6.28921 -28.1003
Income Available to Common Excl. Extra. Items -0.05973 -0.92546 -6.28921 -28.1003
Income Available to Common Incl. Extra. Items -0.05973 -0.92546 -6.28921 -28.1003
Diluted Net Income -0.05973 -0.92546 -6.28921 -28.1003
Diluted Weighted Average Shares 7.82633 7.82633 7.32571 16.6038
Diluted EPS Excluding Extraordinary Items -0.00763 -0.11825 -0.85851 -1.6924
Dividends per Share - Common Stock Primary Issue 0 0
Diluted Normalized EPS -0.00763 -0.11825 -0.7165 -1.71464
Depreciation / Amortization 0.10339 0.18792
Unusual Expense (Income) 1.04032 -0.3692
Other Operating Expenses, Total 10
Other, Net 0.0305
Q1 2021 Q2 2021 Q3 2021 Q4 2021 Q1 2022
Total revenue 0.04885 0.59509 0.68793 1.54441 0.72163
Revenue 0.04885 0.59509 0.68793 1.54441 0.72163
Cost of Revenue, Total 0.02345 0.41391 0.68577 1.21765 0.60442
Gross Profit 0.0254 0.18118 0.00216 0.32676 0.11721
Total Operating Expense 2.24255 4.25323 4.29499 18.4875 3.58335
Selling/General/Admin. Expenses, Total 2.80616 3.68253 2.85939 6.6913 1.85053
Research & Development 0.06053 0.13519 0.722 0.16165 0.10303
Depreciation / Amortization 0.0216 0.0216 0.02784 0.11687 0.02538
Unusual Expense (Income) -0.6692 0.3
Operating Income -2.1937 -3.65814 -3.60706 -16.9431 -2.86172
Interest Income (Expense), Net Non-Operating -0.00206 -0.49293 -1.19626 -0.03752 -0.02071
Net Income Before Taxes -2.19576 -4.15107 -4.80843 -16.945 -2.91978
Net Income After Taxes -2.19576 -4.15107 -4.80843 -16.945 -2.91978
Net Income Before Extra. Items -2.19576 -4.15107 -4.80843 -16.945 -2.91978
Net Income -2.19576 -4.15107 -4.80843 -16.945 -2.91978
Income Available to Common Excl. Extra. Items -2.19576 -4.15107 -4.80843 -16.945 -2.91978
Income Available to Common Incl. Extra. Items -2.19576 -4.15107 -4.80843 -16.945 -2.91978
Diluted Net Income -2.19576 -4.15107 -4.80843 -16.945 -2.91978
Diluted Weighted Average Shares 11.1697 11.3598 19.822 23.9611 23.1341
Diluted EPS Excluding Extraordinary Items -0.19658 -0.36542 -0.24258 -0.70719 -0.12621
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS -0.25649 -0.36542 -0.24258 -0.69467 -0.12621
Other, Net -0.00511 0.03561 -0.03734
Other Operating Expenses, Total 10 1
  • Annual
  • Quarterly
2018 2019 2020 2021
Total Current Assets 0.19132 0.74579 4.98826 16.2798
Cash and Short Term Investments 0.16132 0.53303 4.38528 14.6629
Cash 0.16132 0.53103 4.26217 11.7546
Total Receivables, Net 0.03 0.00231 0.25511 0.69532
Total Assets 0.19132 0.74579 6.52559 18.8675
Total Current Liabilities 0.007 0.33644 2.12567 1.56909
Accounts Payable 0.007 0.01072 0.68884 1.24293
Notes Payable/Short Term Debt 0 0 0.6915 0
Total Liabilities 0.007 0.36658 2.13205 2.26505
Total Long Term Debt 0 0 0 0
Total Equity 0.18432 0.37921 4.39354 16.6024
Common Stock 0.00596 0.33189 0.01066 0.30905
Additional Paid-In Capital 0.23854 1.03251 11.6573 51.668
Retained Earnings (Accumulated Deficit) -0.05973 -0.9852 -7.2744 -35.3746
Other Equity, Total -0.00045 0
Total Liabilities & Shareholders’ Equity 0.19132 0.74579 6.52559 18.8675
Total Common Shares Outstanding 7.82633 7.82633 10.6558 24.046
Short Term Investments 0.002 0.12312 2.9083
Accounts Receivable - Trade, Net 0.00191 0.25511 0.69532
Total Inventory 0.13548 0.22592 0.30427
Prepaid Expenses 0.025 0.09279 0.6173
Other Current Assets, Total 0.04997 0.02916
Accrued Expenses 0.02572 0.13576 0.27861
Current Port. of LT Debt/Capital Leases 0.3 0.60958 0.04755
Other Liabilities, Total 0.03014 0.00638 0.69596
Property/Plant/Equipment, Total - Net 0.03559 0.90637
Property/Plant/Equipment, Total - Gross 0.044
Accumulated Depreciation, Total -0.00841
Goodwill, Net 0.94194 0.94194
Intangibles, Net 0.5598 0.73942
Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
Total Current Assets 3.58851 4.80241 28.4119 16.2798 10.809
Cash and Short Term Investments 3.00779 3.94097 27.1466 14.6629 9.05386
Cash 3.00779 3.94097 26.8533 11.7546 6.14556
Total Receivables, Net 0.01267 0.41512 0.57188 0.69532 0.34869
Accounts Receivable - Trade, Net 0.01267 0.41512 0.57188 0.69532 0.34869
Total Inventory 0.24932 0.25506 0.63703 0.30427 0.47313
Prepaid Expenses 0.29511 0.19126 0.05637 0.6173 0.93337
Other Current Assets, Total 0.02362 0
Total Assets 5.08194 6.32466 31.4492 18.8675 13.2953
Property/Plant/Equipment, Total - Net 0.03339 0.08162 0.9411 0.90637 0.82309
Goodwill, Net 0.94194 0.94194 0.94194 0.94194 0.94194
Intangibles, Net 0.5181 0.49869 1.15429 0.73942 0.7212
Total Current Liabilities 0.65076 2.60758 1.1018 1.56909 1.01993
Accounts Payable 0.45333 0.39817 0.80175 1.24293 0.48824
Accrued Expenses 0.11285 0.12024 0.2157 0.27861 0.4837
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 0.08458 2.08917 0.08435 0.04755 0.04798
Total Liabilities 0.65076 2.60758 1.82178 2.26505 1.64079
Total Long Term Debt 0 0 0 0 0
Other Liabilities, Total 0 0 0.71999 0.69596 0.62087
Total Equity 4.43118 3.71708 29.6274 16.6024 11.6545
Common Stock 0.34711 0.33995 0.25179 0.30905 0.30715
Additional Paid-In Capital 13.5542 16.9984 47.8053 51.668 51.7749
Retained Earnings (Accumulated Deficit) -9.47016 -13.6212 -18.4297 -35.3746 -38.2944
Total Liabilities & Shareholders’ Equity 5.08194 6.32466 31.4492 18.8675 13.2953
Total Common Shares Outstanding 11.2602 11.496 23.344 24.046 20.1541
Short Term Investments 0.2933 2.9083 2.9083
Treasury Stock - Common -2.13317
  • Annual
  • Quarterly
2018 2019 2020 2021
Net income/Starting Line -0.05973 -0.92546 -6.28921 -28.1003
Cash From Operating Activities -0.08273 -0.69274 -2.73274 -7.56765
Non-Cash Items 0 0.3579 3.43846 20.5958
Cash Taxes Paid 0 0 0 0
Cash Interest Paid 0 0 0 0
Changes in Working Capital -0.023 -0.12518 -0.04336 -0.25113
Cash From Financing Activities 0.24405 1.06245 6.70986 28.2066
Financing Cash Flow Items 0 0.00045 0.07082
Issuance (Retirement) of Stock, Net 0.24405 0.762 6.35029 28.3183
Issuance (Retirement) of Debt, Net 0 0.3 0.35958 -0.1825
Net Change in Cash 0.16132 0.36971 3.73114 7.49239
Cash From Operating Activities 0.16137 0.18792
Cash From Investing Activities -0.24599 -13.1466
Capital Expenditures -0.044 -0.2383
Other Investing Cash Flow Items, Total -0.20199 -12.9083
Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
Net income/Starting Line -2.19576 -6.34684 -11.1553 -28.1003 -2.91978
Cash From Operating Activities -1.25438 -3.23705 -5.01717 -7.56765 -2.71287
Cash From Operating Activities 0.0216 0.04442 0.03849 0.18792 0.02538
Non-Cash Items 1.01371 3.453 6.50621 20.5958 1.10727
Cash Taxes Paid 0 0 0 0 0
Cash Interest Paid 0 0 0 0 0
Changes in Working Capital -0.09392 -0.38764 -0.4066 -0.25113 -0.92574
Cash From Investing Activities 0 -0.05165 -0.5275 -13.1466 -0.96129
Capital Expenditures 0 -0.05165 -0.2342 -0.2383 -0.00429
Cash From Financing Activities 0 2.9675 28.1358 28.2066 -1.93484
Issuance (Retirement) of Debt, Net 0 2.9675 -0.1825 -0.1825 0.19832
Net Change in Cash -1.25438 -0.3212 22.5911 7.49239 -5.609
Other Investing Cash Flow Items, Total 0 -0.2933 -12.9083 -0.957
Issuance (Retirement) of Stock, Net 28.3183 28.3183 -2.13317
Financing Cash Flow Items 0.07082
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
John (Brian S) Individual Investor 12.7533 2791556 -1106244 2022-11-03 LOW
The Glenview Trust Company Bank and Trust 9.3269 2041556 0 2022-09-30 LOW
Miller (Richard A) Individual Investor 7.6278 1641044 -9416 2022-07-26 LOW
Wilson (Glynn) Individual Investor 4.3401 950000 -1088944 2022-11-03 MED
Greentree Financial Group, Inc. Corporation 3.3008 722500 722500 2022-05-11
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 1.9412 424897 21052 2022-09-30 LOW
Kepos Capital LP Hedge Fund 1.1421 250000 0 2022-09-30 HIGH
McKinnon (Douglas O) Individual Investor 1.0279 225000 -588944 2022-11-03 HIGH
Fani (Skender) Individual Investor 0.5574 122000 0 2022-11-03 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.4999 109416 0 2022-09-30 LOW
M Holdings Securities, Inc. Investment Advisor 0.3906 85500 0 2022-09-30 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 0.18 39400 0 2022-09-30 LOW
Platform Technology Partners LLC Investment Advisor 0.1729 37839 37839 2022-09-30 LOW
Cordasco Financial Network, Inc. Investment Advisor 0.1371 30000 0 2022-06-30 LOW
Mercer Global Advisors, Inc. Investment Advisor 0.1371 30000 30000 2022-09-30 LOW
Northern Trust Investments, Inc. Investment Advisor/Hedge Fund 0.1281 28047 0 2022-09-30 LOW
Pekin Hardy Strauss Wealth Management Investment Advisor 0.1029 22531 0 2022-09-30 LOW
Triumph Capital Management Investment Advisor 0.064 14000 14000 2022-09-30 MED
Creative Planning, Inc. Investment Advisor/Hedge Fund 0.0457 10010 10 2022-09-30 LOW
Morgan Stanley Smith Barney LLC Investment Advisor 0.0457 10001 0 2022-09-30 LOW

Why choose Capital.com? Our numbers speak for themselves.

Capital.com Group
475000+

Traders

71000+

Active clients monthly

$51000000+

Monthly investing volume

$30000000+

Withdrawn each month

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

Jupiter Wellness, Inc. Company profile

Jupiter Wellness, Inc. develops cannabidiol (CBD) based medical therapeutics and wellness products. The company''s clinical pipeline includes CaniDermRX (JW-100), a novel topical formulation containing CBD and aspartame for the treatment of eczema, dermatitis, and actinic keratosis; JW-101, a prescription product for the treatment of burns; and JW-200, a non-prescription lotion/lip balm for the treatment of symptoms of cold sores. It also manufactures, distributes, and markets a line of consumer products, such as CBD-infused sunscreen under the CaniSun brand; CBD-infused skin care lotion under the CaniSkin brand; and products for the dermatological treatments of pain and inflammation under the CaniDermRX brand. The company was formerly known as CBD Brands, Inc. Jupiter Wellness, Inc. was incorporated in 2018 and is headquartered in Jupiter, Florida.
Industry: Personal Products (NEC)

1061 E. Indiantown Rd.
Ste. 110
JUPITER
FLORIDA 33477
US

Income Statement

People also watch

Oil - Crude

74.94 Price
-3.280% 1D Chg, %
Long position overnight fee -0.0095%
Short position overnight fee -0.0056%
Overnight fee time 22:00 (UTC)
Spread 0.03

BTC/USD

17,020.55 Price
+0.060% 1D Chg, %
Long position overnight fee -0.0500%
Short position overnight fee 0.0140%
Overnight fee time 22:00 (UTC)
Spread 60.00

US100

11,604.10 Price
-1.660% 1D Chg, %
Long position overnight fee -0.0170%
Short position overnight fee 0.0061%
Overnight fee time 22:00 (UTC)
Spread 1.8

XRP/USD

0.39 Price
-0.740% 1D Chg, %
Long position overnight fee -0.0500%
Short position overnight fee 0.0140%
Overnight fee time 22:00 (UTC)
Spread 0.00315

Still looking for a broker you can trust?

Join the 475.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading